These Numbers Could Change Investor Views For Unity Biotechnology Inc (NASDAQ: UBX)
Currently, there are 17.21M common shares owned by the public and among those 15.68M shares have been available to trade. The company’s stock has a 5-day price change of -57.11% and -67.01% over the past three months. UBX shares are trading -75.14% year to date (YTD), with the 12-month market performance down to -64.86% lower. […]